Biodesix, Inc. Overview
Pro stress-test →Biodesix is a leading specialty diagnostic solutions company offering blood-based tests for lung disease that support clinical decisions to improve patient outcomes. The company provides both diagnostic tests and development services that enable biopharmaceutical and research institutions to develop diagnostic tools and therapeutics.
Strategic Profile
Pro stress-test →Biodesix specializes in blood-based molecular diagnostics and precision medicine, operating primarily in lung disease and oncology sectors with innovative diagnostic testing services designed to provide rapid insights based on a patient's unique molecular signature. The company has five Medicare-covered tests for the lung cancer healthcare continuum and partners with BioPharma companies using its unique portfolio of patented technologies.
Competitive Landscape
Pro stress-test →Biodesix operates in the Lifesciences Tools & Diagnostics sector as a leading specialty diagnostics company. Primary competitors include other molecular diagnostics and liquid biopsy firms focusing on oncology testing. Key differentiators include Biodesix's portfolio of five Medicare-covered tests and dual business model combining clinical testing services with biopharma development services.
Industry Context
Biodesix, Inc. operates in Lifesciences Tools & Diagnostics (Molecular Diagnostics, Oncology Testing, Precision Medicine).
Key facts
Founded: 2005 · Headquarters: Louisville, Colorado, United States · Revenue: $13.2M (Q1 2024) · Market cap: $32.2M